Physitrack’s Q1 2025 report marked a solid start to the year, with sales broadly in line and profitability supported by continued cost efficiencies. The Lifecare division delivered stable performance, maintaining high margins and strong recurring revenue growth. In the Wellness division, restructuring efforts began to show results, with some margin improvements despite still-muted top-line growth. The outlook remains positive, with management confident in reaching cash flow neutrality for the full year by balancing revenue growth and margin expansion.
LÄS MER
